Diseases of Immunization and Disease Outbreaks

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2011-10-25
EMA Withdrawn: Arepanrix (split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs.) — GlaxoSmithKline Biologicals S.A.
EMA confirms withdrawal of Arepanrix influenza vaccine (split inactivated H1N1) by GlaxoSmithKline Biologicals S.A. with decision dated 13/0…